Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009853 |
---|---|
Receipt number | R000011543 |
Scientific Title | Phase II trial of Epirubicin / Cyclophosphamide (EC) followed by Nab-paclitaxel as neoadjuvant chemotherapy for node positive breast cancer |
Date of disclosure of the study information | 2013/02/01 |
Last modified on | 2016/08/09 21:44:43 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/01/23 19:12:22 | ||
2 | Update | 2013/08/06 19:00:19 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
3 | Update | 2016/08/09 21:42:45 | TEL Last name of contact person Last name of contact person TEL Name of person sending information Name of person sending information Name of primary person or sponsor Institute Organization Organization Email1 |
|
4 | Update | 2016/08/09 21:44:43 | Recruitment status |